Letter/Comment
The latest advocacy letters and comments from the American Hospital Association.
The American Hospital Association asks the Secretary of Health and Human Services (HHS) to reinstate the COVID-19 Provider Relief Fund (PRF) reporting requirements outlined in your June 19 frequently asked question that defined both expenses and lost revenues attributable to COVID-19.
Nearly 30 representatives encourage House leaders to modify in the next COVID-19 response package impending thresholds for qualifying participants in Advanced Alternative Payment Models, which they said threaten to “derail” the movement to value-based care under the Medicare Access and CHIP…
AHA Comments Submitted In Response to HRSA’s RFI on Health Professional Shortage Area (HPSA) Scoring
AHA's input on the Health Resources and Services Administration’s (HRSA) Health Professional Shortage Area (HPSA) Scoring Criteria request for information (RFI). The RFI solicits comments on the HPSA scoring methodology, including the criteria and measures utilized in calculating the scores.
The AHA requests that the Department of Health and Human Services revise certain FAQs that place problematic restrictions on the use of some CARES Act Provider Relief Fund dollars.
AHA comments on the National Academies of Sciences, Engineering and Medicine’s Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine.
AHA to HHS again expressing concern with recent actions taken by several major drug manufacturers to limit the distribution of certain 340B drugs to our hospital members.
AHA urges the Centers for Medicare & Medicaid Services (CMS) to withdraw the condition of participation that hospitals report daily COVID-19 data.
Letter from AHA to President Donald Trump urging additional support for rural hospitals and health systems.
On behalf of the nation’s 340B hospitals, AHA, others urge HHS to protect vulnerable communities from actions taken by five of the nation’s largest pharmaceutical manufacturers that undermine access to critical drugs and other health care services.
AHA urges the Centers for Medicare & Medicaid Services to provide additional flexibility regarding the agency’s new COVID-19 test documentation requirement for the diagnostic-related group (DRG) add-on payment.